Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Gastric surgery reduces ghrelin levels in the morbidly obese

Ghrelin, a powerful appetite stimulant, is reduced in morbidly obese patients who have undergone gastric surgery, finds a study in the journal Archives of Surgery, suggesting a possible explanation for the rapid loss of hunger and weight in such patients who have had gastric bypass surgery.

News image

fiogf49gjkf04

Ghrelin, which is produced mainly in the stomach, is a potent orexigen or appetite inducing hormone that has been shown to be elevated in states of hunger, but to decline rapidly following a meal.

Researchers from Emory University School of Medicine, Atlanta, USA, were interested to investigate whether the early alterations in ghrelin levels observed in morbidly obese patients undergoing weight reduction surgery may be due to gastric partitioning.

They studied 34 patients who underwent Roux-en-Y gastric bypass with a completely divided gastroplasty to create a 15 mL vertically orientated gastric pouch.

In addition, 8 other patients who underwent less drastic gastric bypass procedures not involving complete division of the stomach were also studied. These included 4 vertical banded gastroplasties and 4 anti-reflux surgical procedures.

A lean control group of 6 additional patients undergoing anti-reflux surgery was also included in the study.

Gastric bypass surgery caused ghrelin levels to drop by almost a third
Archives of surgery

In each case plasma samples were obtained before surgery and immediately after surgery, while in a sub-study, plasma was collected after Roux-en-Y limb formation and after dividing the stomach in order to identify any changes in plasma ghrelin levels.

The researchers found that in the patients not undergoing the gastric bypass procedure (i.e. the vertical banded gastroplasty group and all patients undergoing anti-reflux surgery) there were no significant changes in ghrelin levels following surgery.

This was in marked contrast to the gastric bypass group, where mean preoperative ghrelin levels dropped from 355 pg/mL to 246 pg/mL postoperatively.

Lead researcher Dr Edward Lin said, "This is the first time we have found that different types of weight-loss surgeries affect ghrelin levels in humans. Compared with morbidly obese humans, lean controls had significantly higher plasma ghrelin levels at baseline."

"When the stomach is divided, forming a small gastric pouch, the ghrelin levels are significantly reduced early after the surgery is performed. Other mechanisms can make you hungry, but ghrelin is one of the most potent hunger stimulants."

He added, "This study shows that surgically induced weight loss with Roux-en-Y gastric bypass in these patients appears to cause long-term, if not permanent, suppression of ghrelin secretions that is not associated with other weight-loss procedures and may explain, in part, the loss of hunger sensation and rapid weight loss observed following gastric bypass surgery."

Arch Surg 2004; 139 (7): 780 - 784
22 July 2004

Go to top of page Email this page Email this page to a colleague

 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Autoimmune pancreatitis in children
 01 November 2017 
Heartburn relief in adolescents with GERD
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us